Garnet Equity Capital Holdings’s Bristol-Myers Squibb BMY Stock Holding History

Garnet Equity Capital Holdings’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-40,000	Closed	-$2.72M	–	44
2021 Q3	$2.72M	Buy	+40,000	New	+$2.63M	2.55%	16
2020 Q3	–	Sell	-60,000	Closed	-$3.53M	–	31
2020 Q2	$3.53M	Buy	60,000 +20,000	+50%	+$1.2M	0.7%	14
2020 Q1	$2.23M	Sell	40,000 -20,000	-33%	-$1.22M	0.52%	11
2019 Q4	$3.85M	Buy	+60,000	New	+$3.44M	1.37%	12
2018 Q1	–	Sell	-60,000	Closed	-$3.68M	–	26
2017 Q4	$3.68M	Buy	+60,000	New	+$3.75M	2.94%	17
2016 Q3	$2.7M	Buy	+50,000	New	+$3.21M	0.88%	18

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Garnet Equity Capital Holdings's BMY Position: Q4 2021 in Review

Garnet Equity Capital Holdings sold out of Bristol-Myers Squibb (BMY) in Q4 2021, closing a stake of 40,000 shares — an estimated $2.72M sold.

Garnet Equity Capital Holdings first reported a position in BMY in Q3 2016 and held it in 6 quarters. The position peaked at $3.85M in Q4 2019. 2,445 funds tracked by Wall St. Rank hold BMY as of Q4 2021.

Garnet Equity Capital Holdings reported no remaining Bristol-Myers Squibb position as of Q4 2021 after selling out during the quarter.
Garnet Equity Capital Holdings sold 40,000 Bristol-Myers Squibb shares in Q4 2021, an estimated $2.72M.
Garnet Equity Capital Holdings first reported a position in Bristol-Myers Squibb in Q3 2016 and held it in 6 quarters.
Garnet Equity Capital Holdings's Bristol-Myers Squibb position peaked at $3.85M in Q4 2019.
2,445 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2021.

Based on Garnet Equity Capital Holdings's 13F filing for Q4 2021, filed 3 Feb 2022.